Lawrence Worobetz

1.1k total citations
21 papers, 740 citations indexed

About

Lawrence Worobetz is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Lawrence Worobetz has authored 21 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Hepatology and 4 papers in Surgery. Recurrent topics in Lawrence Worobetz's work include Liver Disease Diagnosis and Treatment (7 papers), Liver Diseases and Immunity (5 papers) and Hepatitis B Virus Studies (4 papers). Lawrence Worobetz is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver Diseases and Immunity (5 papers) and Hepatitis B Virus Studies (4 papers). Lawrence Worobetz collaborates with scholars based in Canada, Netherlands and Singapore. Lawrence Worobetz's co-authors include Gerald Y. Minuk, John Conly, Linda Scully, Laurence M. Blendis, Karen Cauch‐Dudek, Urs P. Steinbrecher, C. N. Williams, Robert J. Bailey, E. Jenny Heathcote and S. Chris Pappas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Lawrence Worobetz

19 papers receiving 712 citations

Peers

Lawrence Worobetz

HEPAT

EPIDE

SURGE

PRM

ONCOL

Rania Elhelaly Egypt

Özlem Durmaz Türkiye

Deniz Duman Türkiye

Maciej Krasnodębski Poland

Karolina M. Wronka Poland

Langnas An United States

Carlo Mansi Italy

Katharina Schwarzkopf Germany

Giovanni Gasbarrini Italy

Levent Filik Türkiye

Rania Elhelaly Egypt

Lawrence Worobetz

303 ×0.7

HEPAT

381 ×0.9

EPIDE

197 ×0.7

SURGE

36 ×0.4

PRM

63 ×0.7

ONCOL

Citations per year, relative to Lawrence Worobetz Lawrence Worobetz (= 1×) peers Rania Elhelaly

Countries citing papers authored by Lawrence Worobetz

Since Specialization

Citations

This map shows the geographic impact of Lawrence Worobetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Worobetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Worobetz more than expected).

Fields of papers citing papers by Lawrence Worobetz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Worobetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Worobetz. The network helps show where Lawrence Worobetz may publish in the future.

Co-authorship network of co-authors of Lawrence Worobetz

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Worobetz. A scholar is included among the top collaborators of Lawrence Worobetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Worobetz. Lawrence Worobetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hirschfield, Gideon M., Ellina Lytvyak, M. Saleem Ismail, et al.. (2024). Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study. Journal of Hepatology. 81(2). 227–237. 13 indexed citations

Worobetz, Lawrence, et al.. (2024). A Case of Autoimmune Myelofibrosis Associated With Autoimmune Hepatitis. Journal of Hematology. 13(4). 158–163.

Worobetz, Lawrence, et al.. (2018). A148 SMARTPHONE APPS FOR IBD DISEASE MANAGEMENT: A QUANTITATIVE EVALUATION. Journal of the Canadian Association of Gastroenterology. 1(suppl_1). 254–255. 2 indexed citations

Chan, Yin, et al.. (2017). Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators. Canadian Journal of Gastroenterology and Hepatology. 2017. 1–6. 1 indexed citations

Worobetz, Lawrence, et al.. (2017). Rates of and Clinical Predictors of Urgent CT Findings on Abdominopelvic CT in Emergency Department Patients with Inflammatory Bowel Disease. Gastroenterology. 152(5). S774–S774. 1 indexed citations

Minuk, Gerald Y., Kim Hawkins, James D. McHattie, et al.. (2013). Treatment of Chronic Hepatitis C in a Canadian Aboriginal Population: Results from the Prairie Study. SHILAP Revista de lepidopterología. 27(12). 707–710. 5 indexed citations

Mansell, Holly, Lawrence Worobetz, T Sylwestrowicz, & A Shoker. (2012). A Retrospective Study of the Framingham Cardiovascular Risk Scores in a Liver Transplant Population. Transplantation Proceedings. 45(1). 308–314. 4 indexed citations

Jones, Jennifer, et al.. (2009). S1025 A Cost-Utility Analysis of Infliximab Compared with Surgery for the Treatment of Ulcerative Colitis; A Public Payer Perspective. Gastroenterology. 136(5). A–172. 1 indexed citations

Zandieh, Iman, Victor Wong, John M. Howard, et al.. (2008). The Use of Budesonide in the Treatment of Autoimmune Hepatitis in Canada. SHILAP Revista de lepidopterología. 22(4). 388–392. 40 indexed citations

10.

Kaita, K., Eric M. Yoshida, Derek Kunimoto, et al.. (2007). [127] Phil PROOF OF CONCEPT STUDY OF CELGOSIVIR IN COMBINATION WITH PEGINTERFERON o-2b AND RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE-1 NON-RESPONDER PATIENTS. Journal of Hepatology. 46. S56–S57. 19 indexed citations

11.

Khandwala, Hasnain, Rajni Chibbar, & Lawrence Worobetz. (2005). A Case of Celiac Disease Presenting With Malabsorption of l-Thyroxine. The Endocrinologist. 15(1). 14–17. 1 indexed citations

12.

Heathcote, E. Jenny, Karen Cauch‐Dudek, Keith O’Rourke, et al.. (1996). Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?. Hepatology. 23(5). 1148–1153. 75 indexed citations

13.

Lane, Peter R., et al.. (1994). Acute hereditary coproporphyria induced by the androgenic/anabolic steroid methandrostenolone (Dianabol). Journal of the American Academy of Dermatology. 30(2). 308–312. 8 indexed citations

14.

Conly, John, et al.. (1994). The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K.. PubMed. 89(6). 915–23. 121 indexed citations

15.

Heathcote, E. Jenny, Karen Cauch‐Dudek, Valery Walker, et al.. (1994). The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 19(5). 1149–1156. 342 indexed citations

16.

Worobetz, Lawrence, et al.. (1993). Evaluation of SeHCAT Test in Determining Ileal Involvement and Dysfunction in Crohn’s Disease. SHILAP Revista de lepidopterología. 7(8). 597–601. 2 indexed citations

17.

Worobetz, Lawrence. (1993). Proton Pump Inhibitors in the Treatment of Acute Gastroesophageal Reflux Disease. SHILAP Revista de lepidopterología. 7(5). 417–421. 1 indexed citations

18.

Worobetz, Lawrence, Fraser Inglis, & Eldon A. Shaffer. (1993). The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.. PubMed. 88(10). 1705–10. 63 indexed citations

19.

Worobetz, Lawrence & David Gerrard. (1985). Gastrointestinal symptoms during exercise in Enduro athletes: prevalence and speculations on the aetiology.. PubMed. 98(784). 644–6. 38 indexed citations

20.

Worobetz, Lawrence, et al.. (1983). Effect of Morphine and butorphanol on gallbladder emptying.. PubMed. 26(1). 70–1.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact